XOMA Royalty Corporation | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,342 results for “XOMA Royalty Corporation”

Trials

View all 347 →

Phase 1 PK Study of XOMA 3AB

24 participants · First posted May 20, 2011

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

9 participants · First posted Oct 31, 2014

Effects of XOMA 052 on Insulin Production in Type 1 Diabetes

22 participants · First posted Feb 11, 2013

Drugs

View all 129 →

XOMA-629

XOMA-089

XOMA-3AB

Organizations

View all 551 →

XOMA Corp

United States

Xoma (US) LLC

United States

Royalty Pharma plc

United States

News

View all 1315 →

XOMA Royalty Corporation to Acquire Turnstone Biologics for $0.34 Per Share Plus Contingent Value Rights

XOMA Royalty Acquires Pulmokine for $20 Million, Expanding PAH Portfolio with Seralutinib

XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology

Page 1 of 235